Stay updated on Olaparib in gBRCA Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A sitewide NIH notice about terminology during the agency transition was added, and the site revision label changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T20:27:14.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T19:53:30.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, with the study content replaced by an error screen and the original study details no longer visible. This blocks access to core trial information such as the study overview, eligibility criteria, outcomes, and locations.
    Difference
    17%
    Check dated 2026-09-22T22:27:46.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    A new revision tag, v3.7.0, appears on the page, replacing the previous v3.6.6. This indicates a minor maintenance release rather than changes to study content.
    Difference
    0.0%
    Check dated 2026-09-15T21:36:08.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Page version updated from v3.6.5 to v3.6.6, a minor backend/metadata change without affecting the study content.
    Difference
    0.0%
    Check dated 2026-09-01T20:03:12.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    A new line appears under the study identifiers: 2014 ( U.S. NIH Grant/Contract ), indicating NIH funding attribution for the trial. The addition adds funding context but does not change the study details or participant information.
    Difference
    0.0%
    Check dated 2026-08-25T19:50:02.000Z thumbnail image

Stay in the know with updates to Olaparib in gBRCA Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page.